Man Chu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Ubiquitin and proteasome pathways 4
- RNA modifications and cancer 3
- Cancer-related gene regulation 2
- Epigenetics and DNA Methylation 2
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Zhiwei Wang (13 shared papers)Xiaoli Hu (2 shared papers)Min Lin (4 shared papers)Miaomiao Ye (2 shared papers)Xueqiong Zhu (3 shared papers)Jing Wang (1 shared paper)Yi Liu (1 shared paper)Xueqiong Zhu (2 shared papers)
- Journals
- Seminars in Cancer Biology (3 papers)Expert Review of Molecular Diagnostics (3 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Molecular Therapy (2 papers)Cancer Letters (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Man Chu
19 papers receiving 786 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 215
- Oncology 227
- Molecular Biology 501
- Immunology 77
- Cell Biology 45
Countries citing papers authored by Man Chu
This map shows the geographic impact of Man Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Chu more than expected).
Fields of papers citing papers by Man Chu
This network shows the impact of papers produced by Man Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Chu. The network helps show where Man Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Man Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 97 | |
| 2 | 2020 | 94 | |
| 3 | 2020 | 88 | |
| 4 | 2021 | 83 | |
| 5 | 2019 | 71 | |
| 6 | 2020 | 68 | |
| 7 | 2014 | 47 | |
| 8 | 2020 | 39 | |
| 9 | 2019 | 32 | |
| 10 | 2021 | 31 | |
| 11 | 2020 | 31 | |
| 12 | 2020 | 30 | |
| 13 | 2021 | 23 | |
| 14 | 2022 | 20 | |
| 15 | USP7 stabilizes EZH2 and enhances cancer malignant progression. | 2020 | 18 |
| 16 | 2023 | 8 | |
| 17 | 2024 | 5 | |
| 18 | 2019 | 5 | |
| 19 | 2023 | 4 |
About Man Chu
Man Chu is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 794 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer-related gene regulation (2 papers), Epigenetics and DNA Methylation (2 papers), MicroRNA in disease regulation (2 papers) and Advanced Proteomics Techniques and Applications (1 paper). The work is most often cited by research in Cancer Research (215 citations), Oncology (227 citations), Molecular Biology (501 citations), Immunology (77 citations) and Cell Biology (45 citations). Man Chu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhiwei Wang, Xiaoli Hu, Min Lin, Miaomiao Ye, Xueqiong Zhu, Jing Wang, Yi Liu, Xueqiong Zhu, Yizuo Song and Xian Shen. Their work appears in journals such as Seminars in Cancer Biology, Expert Review of Molecular Diagnostics, Arteriosclerosis Thrombosis and Vascular Biology, Molecular Therapy and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.